{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:59:11Z","timestamp":1793383151538,"version":"4.5.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Bilimsel Ara\u015ftirma Projeleri, Kahramanmaras Sutcu Imam University","award":["2019\/2\u201334M"],"award-info":[{"award-number":["2019\/2\u201334M"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>We aimed to evaluate sarcopenia and sarcopenic obesity (SO) in patients with type 2 diabetes mellitus (T2DM), possible relationships with serum irisin and myostatin levels, and the effect of glycemic control on SO.<\/jats:p>\n            <jats:p>Ninety T2DM patients were included in this a cross-sectional study. Sarcopenia was determined by evaluating muscle mass (bioelectrical impedance analysis), muscle strength (HGS), and gait speed (GS). Patients with muscle mass loss with functionally reduced muscle strength and\/or performance were considered sarcopenic. In addition, participants were divided into 3 groups according to the FM (fat mass)\/FFM (fat-free mass) ratio [group 1:5th-50th percentiles; group 2:50th-95th percentiles and group 3: \u226595 percentiles (sarcopenic obese)]. Irisin, myostatin levels and metabolic parameters were measured in all patients.<\/jats:p>\n            <jats:p>The prevalence of sarcopenia and SO was 25.6% and 35.6%, respectively. Irisin levels were lower in sarcopenic patients, while glycosylated hemoglobin (A1c), body mass index (BMI), FM, and FM index were higher (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05). From group 1 to group 3, BMI, FM, FM index, GS, myostatin, and A1c increased, and muscle mass percentage, HGS, and irisin decreased (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05). A positive correlation was found between FM\/FFM and myostatin and a negative correlation between FM\/FFM and irisin (r\u200a=\u200a0.303, <jats:italic toggle=\"yes\">P\u200a=\u200a<\/jats:italic>.004 vs. r\u200a=\u200a\u22120.491, <jats:italic toggle=\"yes\">P\u200a&lt;\u200a<\/jats:italic>.001). Irisin remained an important predictor of SO, even after adjusting for confounding variables (OR:1.105; 95% CI:0.965\u20131.338, <jats:italic toggle=\"yes\">P\u200a=\u200a<\/jats:italic>.002). The optimal cut-off value for irisin to predict SO was 9.49 ng\/mL (specificity\u200a=\u200a78.1%, sensitivity\u200a=\u200a75.8%). In addition, A1c was an independent risk factor for SO development (OR:1.358, <jats:italic toggle=\"yes\">P\u200a=\u200a<\/jats:italic>.055).<\/jats:p>\n            <jats:p>This study showed that low irisin levels (&lt;9.49ng\/mL) and poor glycemic control in T2DM patients were an independent risk factor, especially for SO.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000026529","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T13:46:35Z","timestamp":1625060795000},"page":"e26529","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":47,"title":["Irisin is a predictor of sarcopenic obesity in type 2 diabetes mellitus"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9518-8610","authenticated-orcid":false,"given":"Ayten","family":"Oguz","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Istinye University, Istanbul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Sahin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Tuzun","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ergul B.","family":"Kurutas","sequence":"additional","affiliation":[{"name":"Department of Biochemistry"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cansu","family":"Ulgen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozlem","family":"Bozkus","sequence":"additional","affiliation":[{"name":"Department of Biochemistry"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamile","family":"Gul","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Istinye University, Istanbul"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,7,2]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment","volume":"21","author":"Chen","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.2337\/dc09-0264","article-title":"Excessive loss of skeletal muscle mass in older adults with type 2 diabetes","volume":"32","author":"Seok","year":"2009","journal-title":"Diabetes Care"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jdiacomp.2017.05.003","article-title":"Frailty and sarcopenia\u2014newly emerging and high impact complications of diabetes","volume":"31","author":"Sinclair","year":"2017","journal-title":"J Diabetes Complications"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.2337\/dc10-0107","article-title":"Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA)","volume":"33","author":"Lim","year":"2010","journal-title":"Diabetes Care"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2337\/dc09-2310","article-title":"Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: The Korean Sarcopenic Obesity Study (KSOS)","volume":"33","author":"Kim","year":"2010","journal-title":"Diabetes Care"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"e100118","DOI":"10.1371\/journal.pone.0100118","article-title":"Association of low muscle mass and combined low muscle mass and visceral obesity with low cardiorespiratory fitness","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"21","DOI":"10.14283\/jfa.2017.33","article-title":"The vicious cycle of myostatin signaling in sarcopenic obesity: myostatin role in skeletal muscle growth, insulin signaling and implications for clinical trials","volume":"7","author":"Consitt","year":"2018","journal-title":"J Frailty Aging"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1365-2265.2011.04120.x","article-title":"Serum myostatin levels and grip strength in normal subjects and patients on maintenance haemodialysis","volume":"75","author":"Han","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s00223-014-9894-z","article-title":"Lean mass, muscle strength and gene expression in community dwelling older men: findings from the Hertfordshire Sarcopenia Study (HSS)","volume":"95","author":"Patel","year":"2014","journal-title":"Calcif Tissue Int"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2337\/db08-0943","article-title":"Increased secretion and expression of myostatin in skeletal muscle from extremely obese women","volume":"58","author":"Hittel","year":"2009","journal-title":"Diabetes"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/apha.12631","article-title":"Myostatin in relation to physical activity and dysglycaemia and its effect on energy metabolism in human skeletal muscle cells","volume":"217","author":"Hjorth","year":"2016","journal-title":"Acta Physiol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1111\/ggi.13030","article-title":"Circulating irisin levels as a predictive biomarker for sarcopenia: a cross-sectional community-based study","volume":"17","author":"Chang","year":"2017","journal-title":"Geriatr Gerontol Int"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ijo.2015.200","article-title":"Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues","volume":"40","author":"Dong","year":"2016","journal-title":"Int J Obes"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"e94235","DOI":"10.1371\/journal.pone.0094235","article-title":"Association of serum irisin with metabolic syndrome in obese Chinese adults","volume":"9","author":"Yan","year":"2014","journal-title":"PLoS One"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.arr.2015.05.001","article-title":"Sarcopenia\u2014The search for emerging biomarkers","volume":"22","author":"Kalinkovich","year":"2015","journal-title":"Ageing Res Rev"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5606\/tftrd.2018.1068","article-title":"The effect of blood glucose regulation on sarcopenia parameters in obese and diabetic patients","volume":"64","author":"Ozt\u00fcrk","year":"2018","journal-title":"Turkish J Phys Med Rehabil"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2337\/db05-1183","article-title":"Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study","volume":"55","author":"Park","year":"2006","journal-title":"Diabetes"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1186\/s13098-018-0326-5","article-title":"Sarcopenia: a chronic complication of type 2 diabetes mellitus","volume":"10","author":"Trierweiler","year":"2018","journal-title":"Diabetol Metab Syndr"},{"key":"R20-20250504","article-title":"Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review","author":"Donini","year":"2019","journal-title":"Clin Nutr"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.maturitas.2016.03.018","article-title":"Association of anthropometric measures with fat and fat-free mass in the elderly: The Rotterdam study","volume":"88","author":"Dhana","year":"2016","journal-title":"Maturitas"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.clnu.2012.06.010","article-title":"Sarcopenic obesity: a critical appraisal of the current evidence","volume":"31","author":"Prado","year":"2012","journal-title":"Clin Nutr"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s11357-012-9423-9","article-title":"Adiposity to muscle ratio predicts incident physical limitation in a cohort of 3153 older adults-an alternative measurement of sarcopenia and sarcopenic obesity","volume":"35","author":"Auyeung","year":"2013","journal-title":"Age (Omaha)"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12020-015-0758-8","article-title":"Relationship between myostatin and irisin in type 2 diabetes mellitus: a compensatory mechanism to an unfavourable metabolic state?","volume":"52","author":"Garc\u00eda-Fontana","year":"2016","journal-title":"Endocrine"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1532-5415.2002.50216.x","article-title":"Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability","volume":"50","author":"Janssen","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"46","DOI":"10.20463\/jenb.2016.09.20.3.7","article-title":"The reliability and validity of gait speed with different walking pace and distances against general health, physical function, and chronic disease in aged adults","volume":"20","author":"Kim","year":"2016","journal-title":"J Exerc Nutrition Biochem"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.clnu.2017.09.021","article-title":"Fat mass to fat-free mass ratio reference values from NHANES III using bioelectrical impedance analysis","volume":"37","author":"Xiao","year":"2018","journal-title":"Clin Nutr"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ejcn.2017.27","article-title":"Quantification of whole-body and segmental skeletal muscle mass using phase-sensitive 8-electrode medical bioelectrical impedance devices","volume":"71","author":"Bosy-Westphal","year":"2017","journal-title":"Eur J Clin Nutr"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/ageing\/afy106","article-title":"The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: A systematic review and meta-analyses","volume":"48","author":"Mayhew","year":"2019","journal-title":"Age Ageing"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/jdi.12392","article-title":"Difference between old and young adults in contribution of \u03b2-cell function and sarcopenia in developing diabetes mellitus. J","volume":"7","author":"Koo","year":"2016","journal-title":"Diabetes Investig"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.jamda.2016.07.007","article-title":"Frailty and sarcopenia as predictors of adverse health outcomes in persons with diabetes mellitus","volume":"17","author":"Liccini","year":"2016","journal-title":"J Am Med Dir Assoc"},{"key":"R36-20250504","first-page":"e18708","article-title":"A cross-sectional study: associations between sarcopenia and clinical characteristics of patients with type 2 diabetes","volume":"99","author":"Cui","year":"2020","journal-title":"Med (United States)"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.clnu.2019.10.019","article-title":"The prevalence of sarcopenic obesity and its association with cognitive performance in type 2 diabetes in Singapore","volume":"39","author":"Low","year":"2019","journal-title":"Clin Nutr"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s11596-012-0092-9","article-title":"Increased circulating myostatin in patients with type 2 diabetes mellitus","volume":"32","author":"Wang","year":"2012","journal-title":"J Huazhong Univ Sci Technol\u2014Med Sci"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature10777","article-title":"A PGC1-\u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis","volume":"481","author":"Bostr\u00f6m","year":"2012","journal-title":"Nature"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"61","DOI":"10.23736\/S0391-1977.17.02663-3","article-title":"Lower irisin levels in coronary artery disease: a meta-analysis","volume":"45","author":"Guo","year":"2020","journal-title":"Minerva Endocrinol"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jdiacomp.2013.03.002","article-title":"Lower circulating irisin is associated with type 2 diabetes mellitus","volume":"27","author":"Liu","year":"2013","journal-title":"J Diabetes Complications"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"E769","DOI":"10.1210\/jc.2012-2749","article-title":"Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance","volume":"98","author":"Moreno-Navarrete","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1113\/jphysiol.2013.264655","article-title":"Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies","volume":"592","author":"Kurdiova","year":"2014","journal-title":"J Physiol"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/gerona\/gln018","article-title":"Elevated serum advanced glycation end products and poor grip strength in older community-dwelling women","volume":"64","author":"Dalal","year":"2009","journal-title":"Journals Gerontol - Ser A Biol Sci Med Sci"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/10739680600618918","article-title":"Effect of inflammation on the aging microcirculation: impact on skeletal muscle blood flow control","volume":"13","author":"Payne","year":"2006","journal-title":"Microcirculation"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/jdi.13070","article-title":"Hyperglycemia in non-obese patients with type 2 diabetes is associated with low muscle mass: the multicenter study for clarifying evidence for sarcopenia in patients with diabetes mellitus","volume":"10","author":"Sugimoto","year":"2019","journal-title":"J Diabetes Investig"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1136\/bmjdrc-2017-000404","article-title":"Association of diabetic retinopathy with both sarcopenia and muscle quality in patients with type 2 diabetes: a cross sectional study","volume":"5","author":"Fukuda","year":"2017","journal-title":"BMJ Open Diabetes Res Care"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026529","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:33:42Z","timestamp":1746336822000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026529"}},"subtitle":["A cross-sectional study"],"short-title":[],"issued":{"date-parts":[[2021,7,2]]},"references-count":44,"journal-issue":{"issue":"26","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000026529","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,2]]},"assertion":[{"value":"2021-03-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}